全文获取类型
收费全文 | 914篇 |
免费 | 74篇 |
国内免费 | 63篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 51篇 |
妇产科学 | 3篇 |
基础医学 | 115篇 |
口腔科学 | 24篇 |
临床医学 | 76篇 |
内科学 | 201篇 |
皮肤病学 | 30篇 |
神经病学 | 17篇 |
特种医学 | 265篇 |
外科学 | 37篇 |
综合类 | 60篇 |
预防医学 | 28篇 |
眼科学 | 5篇 |
药学 | 98篇 |
肿瘤学 | 39篇 |
出版年
2022年 | 2篇 |
2021年 | 11篇 |
2020年 | 4篇 |
2019年 | 3篇 |
2018年 | 9篇 |
2017年 | 6篇 |
2016年 | 8篇 |
2015年 | 11篇 |
2014年 | 18篇 |
2013年 | 16篇 |
2012年 | 5篇 |
2011年 | 8篇 |
2010年 | 19篇 |
2009年 | 28篇 |
2008年 | 10篇 |
2007年 | 42篇 |
2006年 | 19篇 |
2005年 | 30篇 |
2004年 | 10篇 |
2003年 | 12篇 |
2002年 | 11篇 |
2001年 | 27篇 |
2000年 | 11篇 |
1999年 | 24篇 |
1998年 | 56篇 |
1997年 | 63篇 |
1996年 | 57篇 |
1995年 | 58篇 |
1994年 | 35篇 |
1993年 | 43篇 |
1992年 | 14篇 |
1991年 | 19篇 |
1990年 | 23篇 |
1989年 | 48篇 |
1988年 | 38篇 |
1987年 | 35篇 |
1986年 | 18篇 |
1985年 | 26篇 |
1984年 | 17篇 |
1983年 | 11篇 |
1982年 | 18篇 |
1981年 | 23篇 |
1980年 | 28篇 |
1979年 | 18篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1974年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有1051条查询结果,搜索用时 15 毫秒
31.
32.
33.
The molecular circuitries controlling the process of skin wound healing have gained new significant insights in recent years. This knowledge is built on landmark studies on skin embryogenesis, maturation, and differentiation. Furthermore, the identification, characterization, and elucidation of the biological roles of adult skin epithelial stem cells and their influence in tissue homeostasis have provided the foundation for the overall understanding of the process of skin wound healing and tissue repair. Among numerous signaling pathways associated with epithelial functions, the PI3K/Akt/mTOR signaling route has gained substantial attention with the generation of animal models capable of dissecting individual components of the pathway, thereby providing a novel insight into the molecular framework underlying skin homeostasis and tissue regeneration. In this review, we focus on recent findings regarding the mechanisms involved in wound healing associated with the upregulation of the activity of the PI3K/Akt/mTOR circuitry. This review highlights critical findings on the molecular mechanisms controlling the activation of mTOR, a downstream component of the PI3K–PTEN pathway, which is directly involved in epithelial migration and proliferation. We discuss how this emerging information can be exploited for the development of novel pharmacological intervention strategies to accelerate the healing of critical size wounds. 相似文献
34.
35.
36.
Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection 总被引:2,自引:0,他引:2
Novales JS; Salva AM; Modanlou HD; Kaplan DL; del Castillo J; Andersen J; Medlock ES 《Blood》1993,81(4):923-927
Maternally administered recombinant human granulocyte colony- stimulating factor (rhG-CSF) has been shown to cross the placenta and induce a peripheral neutrophilia and increases in the marrow and spleen neutrophil storage pools in fetal and newborn rats. In the present study, we have used this model system to investigate the efficacy of prenatally administered rhG-CSF on neonatal defense to a lethal challenge with Group B-beta hemolytic Streptococcus (GBS). Pregnant rats were injected with rhG-CSF twice daily beginning 6 days before parturition. At birth, all pups were infected with a dose of GBS that is lethal for 90% of infected pups (LD90). Survival was monitored daily for 5 days. Survival of infected pups from saline-treated mothers beyond 60 hours after infection was 10%. No difference in survival was observed among pups from mothers treated 2 and 4 days before parturition. In contrast, we determined that survival was 82.5% among infected pups from mothers treated for 6 days before parturition with rhG-CSF. Our results demonstrate that maternal administration of rhG- CSF augments neonatal defenses against a lethal bacterial challenge. 相似文献
37.
STUDY OBJECTIVE: The accurate and inexpensive noninvasive assessment of the presence and severity of aortic stenosis remains a challenge. In this study, we performed spectral analysis on the murmurs of a group of patients with this disease in order to assess its severity. DESIGN: An electronic stethoscope was used to generate a spectral analysis of murmurs in patients with aortic stenosis. The durations of the spectra at different frequencies (ie, 200, 250, and 300 Hz) were correlated to the Doppler echocardiogram-derived mean and peak pressure gradients. Heart murmurs from the patients were recorded, and the spectra of the recordings were produced via fast-Fourier transformation. The duration of the spectra above the three given frequencies was then measured. PATIENTS: Forty-one patients (age range, 45 to 94 years; mean age, 68 years) met the inclusion criteria, which included a minimum ejection fraction of 40% and no other significant systolic murmur or coexistent valve disease. RESULTS: The peak pressure gradient measured via Doppler echocardiogram ranged from 15.3 to 185 mm Hg with the mean of 63 mm Hg. The duration of the spectra of > 300 Hz correlated best with the peak pressure gradient measured using the Doppler echocardiogram. An exponential regression model was created showing a significant correlation coefficient of r = 0.86 (p < 0.0001). CONCLUSIONS: This study demonstrated a good correlation between the duration of spectra at 300 Hz and the Doppler derived peak pressure gradient. This simple and inexpensive technique may prove to be valuable in the evaluation and monitoring of patients with suspected and proven aortic stenosis. 相似文献
38.
The effects of granulocyte-macrophage colony-stimulating factor (GM- CSF) are not confined to cells of the myeloid lineage. GM-CSF has been shown to have effects on mature T cells and both mature and immature T- cell lines. We therefore examined the GM-CSF responsiveness of murine thymocytes to investigate whether GM-CSF also affected normal immature T lymphocytes. The studies presented here indicate that GM-CSF augments accessory cell (AC)-dependent T-cell receptor (TCR)-mediated proliferation of unseparated thymocyte populations. To identify the GM- CSF responsive cell type, thymic AC and T cells were examined for GM- CSF responsiveness. We found that GM-CSF augmentation of TCR-induced thymocyte proliferation appears to be mediated via augmentation of AC function, and not via direct effects on mature single-positive (SP) thymocytes. Enriched double-negative (DN) thymocytes were also tested for GM-CSF responsiveness. GM-CSF induced the proliferation of adult and fetal DN thymocytes in an AC-independent and TCR-independent single- cell assay. Thus, in contrast to the SP thymocytes, a DN thymocyte population was directly responsive to GM-CSF. GM-CSF therefore may play a direct role in the expansion of DN thymocytes and an indirect role in the expansion of SP thymocytes. 相似文献
39.
Weisdorf DJ; Verfaillie CM; Davies SM; Filipovich AH; Wagner JE Jr; Miller JS; Burroughs J; Ramsay NK; Kersey JH; McGlave PB 《Blood》1995,85(12):3452-3456
Delay in hematologic recovery after bone marrow transplantation (BMT) can extend and amplify the risks of infection and hemorrhage, compromise patients' survival, and increase the duration and cost of hospitalization. Because current studies suggest that granulocyte- macrophage (GM) colony-stimulating factor (CSF) may potentiate the sensitivity of hematopoietic progenitor cells to G-CSF, we performed a prospective, randomized trial comparing GM-CSF (250 micrograms/m2/d x 14 days) versus sequential GM-CSF x 7 days followed by G-CSF (5 micrograms/kg/d x 7 days) as treatment for primary or secondary graft failure after BMT. Eligibility criteria included failure to achieve a white blood cell (WBC) count > or = 100/microL by day +21 or > or = 300/microL by day +28, no absolute neutrophil count (ANC) > or = 200/microL by day +28, or secondary sustained neutropenia after initial engraftment. Forty-seven patients were enrolled: 23 received GM-CSF (10 unrelated, 8 related allogeneic, and 5 autologous), and 24 received GM- CSF followed by G-CSF (12 unrelated, 7 related allogeneic, and 5 autologous). For patients receiving GM-CSF alone, neutrophil recovery (ANC > or = 500/microL) occurred between 2 and 61 days (median, 8 days) after therapy, while those receiving GM-CSF+G-CSF recovered at a similar rate of 1 to 36 days (median, 6 days; P = .39). Recovery to red blood cell (RBC) transfusion independence was slow, occurring 6 to 250 days (median, 35 days) after enrollment with no significant difference between the two treatment groups (GM-CSF: median, 30 days; GM-CSF+G- CSF; median, 42 days; P = .24). Similarly, platelet transfusion independence was delayed until 4 to 249 days (median, 32 days) after enrollment, with no difference between the two treatment groups (GM- CSF: median, 28 days; GM-CSF+G-CSF: median, 42 days; P = .38). Recovery times were not different between patients with unrelated donors and those with related donors or autologous transplant recipients. Survival at 100 days after enrollment was superior after treatment with GM-CSF alone. Only 1 of 23 patients treated with GM-CSF died versus 7 of 24 treated with GM-CSF+G-CSF who died 16 to 84 days (median, 38 days) after enrollment, yielding Kaplan-Meier 100-day survival estimates of 96% +/- 8% for GM-CSF versus 71% +/- 18% for GM-CSF+G-CSF (P = .026). These data suggest that sequential growth factor therapy with GM-CSF followed by G-CSF offers no advantage over GM-CSF alone in accelerating trilineage hematopoiesis or preventing lethal complications in patients with poor graft function after BMT.(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献
40.